Back

Socioeconomic factors and SGLT2 inhibitor prescription in heart failure a retrospective analysis using real-world data

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Public health and cardiovascular disease Public Health ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Lisa-Marie Mueller

Leipzig (Germany)

12 More presentations in this session

Presentation thumbnail
Discussant - Public health and cardiovascular disease
Presentation thumbnail
A value-based analysis of the systematic use of dapagliflozin in patients with heart failure
Professor H. Bueno (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Economic burden of elevated lipoprotein(a) in secondary prevention atherosclerotic cardiovascular disease cohort from England
Mrs M. Caido (London, GB)
Abstract Slides Video
Presentation thumbnail
Chronic disease trajectory network and Monte Carlo simulation in Chinese population
Doctor J. Fei (Beijing, CN)
Abstract
Presentation thumbnail
Multiscale entropy, a novel non-linear method, better reflected the detrimental impact of ambient air pollution on 24-hour heart rate variability than linear method or detrended fluctuation analysis
Doctor C. Huang (Taipei, TW)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Public health and cardiovascular disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Socioeconomic disparities in guideline directed medical therapy for HFrEF: a population-based cohort study using electronic health records (the Netherlands)
thumbnail
Congress Presentation
Real-world use of empaglifozin and dapaglifozin in patients with HEART failure
thumbnail
Congress Presentation
A real-world population with HFrEF treated with dapagliflozin or empagliflozin: a comparative analysis with DAPA-HF and EMPEROR REDUCED studies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources